Deckers Stock Tanks on Weak Forecast – Is a Rebound Coming?

Deckers Stock Crashes on Tepid Outlook – Is a Big Bounce Back Brewing?

  • Recent Price Action: Deckers (NYSE: DECK) closed around $102.50 on Oct. 23, 2025 ts2.tech, roughly 33% below its level a year ago. Trading had been choppy (roughly $99–$103 in early Oct.), but the stock plummeted ~9–12% in after-hours trading following its Oct. 23 earnings release ts2.tech Reuters. (If prices hold, this would mark one of DECK’s largest drops in months.)
  • Q2 Earnings Beat: In Q2 FY2026 (quarter ending Sept. 30), Deckers reported revenue of $1.431 billion (+9.1% year-over-year) and EPS $1.82 Deckers. Both figures topped Wall Street’s roughly $1.42 billion and $1.58 estimates Reuters. Growth was broad: HOKA brand sales jumped ~11.1% (to $634.1 M) and UGG sales +10.1% (to $759.6 M) Deckers, led by strong demand overseas. (U.S. sales dipped ~1.7% Deckers.)
  • Mixed Guidance: Deckers raised its full-year forecast but missed analysts’ targets. The company now expects FY2026 sales of about $5.35 billion and EPS of $6.30–$6.39 Deckers – below the roughly $5.45 B sales and $6.32 EPS Wall Street had anticipated Reuters. Management cited “rising economic uncertainty” and tariff impacts (now estimated at ~$150 M) as headwinds Reuters Reuters.
  • Market Reaction: The weak outlook spooked investors. DECK shares fell sharply in after-hours trading (about 12% down, according to Reuters Reuters) and ended Oct. 23 in the mid-$90s ts2.tech. By contrast, many retail peers (like Nike and Adidas) recently beat forecasts and even raised guidance ts2.tech, highlighting the split in the industry. (U.S. holiday spending is expected to grow only modestly this year, as consumers stay cautious Reuters Reuters.)
  • Analyst Views: Wall Street took notice. Analysts have cut price targets and ratings: for example, Jefferies trimmed its 12-month target to $107 (Hold) ts2.tech, and Bernstein started coverage at Underperform ($100) in mid-Oct ts2.tech. According to MarketBeat, price targets on Deckers now range roughly $100–$136, with a consensus “Moderate Buy” and average target around $136 Marketbeat Marketbeat. (Seaport research recently lowered Q3 EPS estimates to $2.75 Marketbeat.) Overall sentiment is cautious: many analysts have “Hold/Neutral” ratings, reflecting the near-term uncertainty ts2.tech.
  • Balance Sheet & Brands: Deckers enters this period in strong financial shape. The company is debt-free with ~$1.4 B cash on hand, and it bought back ~$282 M of stock in Q2 Deckers (over 2.6 M shares at ~$109 each). Its key brands – HOKA and UGG – continue to drive growth (each up double-digits internationally) Deckers ts2.tech, which underpins long-term optimism. (For context, Deckers’ previous CEO noted in 2024 that “Hoka and Ugg are two of the healthiest brands in the industry” Retaildive.)

Stock Performance & Recent Trend

Deckers’ share price had been trading around the low-$100s in mid-October 2025. On Oct. 23, 2025 it closed at about $102.54 ts2.tech. Trading volumes spiked into the millions on that day (roughly 8.8M shares, well above normal), as investors braced for earnings. Early on Oct. 23, DECK was up slightly for the week, but the big move came after markets closed. In after-hours trading on Oct. 23, DECK plunged roughly 9–12% into the mid-$90s ts2.tech Reuters. This wiped out most of the day’s gains and reflected investor nervousness. (By contrast, over the past 12 months DECK is down about 32–33% ts2.tech.)

As of Oct. 24, 2025, Deckers stock remains well below its spring 2024 highs (~$220) and trades at a modest valuation (around 15–17× forward earnings ts2.tech Nasdaq). The sharp post-earnings drop pushed sentiment to be short-term negative, with many traders moving to the sidelines until signs of stabilization.

Q2 Earnings and Guidance

On Oct. 23, 2025 Deckers reported its second-quarter (fiscal Q2 FY2026) results. The company delivered strong top- and bottom-line growth, easily beating expectations Deckers Reuters. Net sales were $1.431 billion, up 9.1% year-over-year Deckers, above analysts’ $1.42 B forecast Reuters. Earnings-per-share were $1.82, up 14% from a year ago Deckers and topping the ~$1.58 consensus Reuters. Growth came largely from Deckers’ flagship brands: HOKA sales jumped 11.1% to $634.1 M and UGG sales rose 10.1% to $759.6 M Deckers. These gains were fueled by international demand and new products. (Other smaller brands like Teva/Sanuk accounted for most of the slight sales declines.) Notably, domestic U.S. sales slipped ~1.7% Deckers, highlighting that U.S. consumers are becoming more cautious.

After the beat, Deckers updated its outlook. The company now forecasts FY2026 net sales of roughly $5.35 billion and EPS in a $6.30–$6.39 range Deckers. Although this is an increase over prior guidance, it fell short of Wall Street’s expectations (Street consensus was near $5.45 B and $6.32 EPS) Reuters. Management explicitly warned that tariffs and inflation are pressuring consumer spending: CEO Stefano Caroti noted “a more cautious consumer” in the U.S. due to tariff- and price-related impacts Reuters. The company now estimates an unmitigated tariff drag of about $150 million this year (down from $185M prior). In sum, Deckers beat the quarter but its full-year guidance was conservative, citing economic uncertainty Reuters Reuters.

Analyst and Expert Commentary

Financial analysts reacted swiftly to the cautious guide. Immediately after the call, many price targets were cut. For example, Jefferies trimmed its 12-month Deckers target to $107 (maintaining a Hold rating) ts2.tech. Sanford Bernstein, which began coverage mid-October, opened with an Underperform rating and a $100 target ts2.tech. Other firms (TD Cowen, UBS, Evercore, etc.) have also lowered targets in recent weeks. According to a MarketBeat report, analyst price targets on DECK now span roughly $100 to $136, with a consensus “Moderate Buy” and average target about $136 Marketbeat Marketbeat. Zacks Investment Research has Deckers at a #3 (Hold) rating (reflecting lowered EPS estimates) and notes DECK’s forward P/E is about 15.7 Nasdaq – slightly below the sector average, implying the stock isn’t overly expensive given its growth.

Expert voices highlighted the same themes. eMarketer analyst Rachel Wolff called the forecast “disappointing” but understood the caution going into a potentially tough holiday season Reuters. On calls, management emphasized a conservative stance. Still, some longer-term bulls see opportunity: Deckers’ strong cash position ($1.4B cash, no debt) and core brand momentum may support a rebound if conditions improve. For example, an analyst noted that at ~15–17× expected 2026 EPS, Deckers’ valuation already “prices in significant uncertainty” ts2.tech. In other words, the risk may be largely reflected in the current price.

Broader Market and Retail Context

Deckers’ results and outlook came amid a mixed retail environment. Broadly, U.S. consumer sentiment has remained cautious. Recent data show middle- and lower-income shoppers are pinching pennies under high prices Reuters, while higher-income consumers continue spending (especially on premium products). The November–December holiday season is expected to see only modest sales growth – forecasts hover around ~2–2.5% gains Reuters, down from ~4% last year – as trade tensions and inflation dampen exuberant spending Reuters Reuters. Several large retailers have given mixed signals: Walmart and Macy’s raised outlooks, but others like Mattel cut guidance Reuters. This cautious backdrop helps explain Deckers’ conservative guidance.

Meanwhile, some of Deckers’ peers have had brighter reports. For example, Nike recently beat revenue targets and said it’s clearing excess inventory (its stock jumped ~4.5% in early October) ts2.tech. Adidas also raised its profit outlook on Oct. 23, noting it largely absorbed U.S. tariff costs through price hikes ts2.tech. In this setting, Deckers’ weaker consumer tone stands out. Interest rates may play a role: futures markets see a Fed rate cut as likely by late Oct. 2025 ts2.tech. If borrowing costs ease, consumer spending could slowly revive in 2026. That potential recovery (and Deckers’ cost of capital) is something investors will watch closely.

Sector-wise, Deckers sits in the Consumer Discretionary – Apparel & Footwear group. As an “affordable luxury” footwear maker, it straddles performance and lifestyle. High-end footwear has still shown resilience (as wealthier buyers remain strong) Reuters. Deckers’ stock has suffered more than the average retailer this year – partly because it was a high-flyer in 2021–22 (with a peak above $223) and now the pullback looks bigger. For context, the stock’s 12-month low is around $93.7 Marketbeat (hit during the recent drop) and high was $223.98 (in mid-2023) Marketbeat.

Company & Brands Overview

Deckers Outdoor is best known for its global footwear brands. Its biggest contributors are HOKA (running shoes) and UGG (shearling-lined boots). Both saw double-digit growth in the recent quarter Deckers. UGG, originally famous for sheepskin boots, has broadened into fashion and outdoors; HOKA has become a leader in high-performance running shoes. Deckers also owns smaller labels (Teva, Sanuk, Koolaburra), but those have much lower sales (Koolaburra is being phased out, for example Deckers). Management has repeatedly said that HOKA and UGG are key growth drivers going forward. In fact, in prior earnings the CEO has called them “incredible – and still increasing – brand heat” Retaildive. For FY2026, Deckers expects HOKA sales to grow in the low-teens and UGG in the low- to mid-single digits Deckers, reflecting slower U.S. demand but strong international momentum.

The company’s strategy is to capitalize on these brands with new product lines, global expansion, and by managing inventory tightly. Deckers also points to its strong balance sheet as a competitive advantage – it reported zero debt and is aggressively buying back shares (with $2.2B still authorized Deckers). These factors give it flexibility in tough times.

Outlook and Takeaways

In summary, Deckers’ stock is under pressure after the latest results. The disappointing full-year guidance (despite a solid quarter) triggered a sharp sell-off ts2.tech Reuters. Analysts and investors are now watching several things for signs of recovery: Will U.S. consumer demand stabilize? Can tariffs and costs be absorbed? How will holiday sales (Nov–Dec) shape up? If Deckers can restart growth or if consumer confidence improves, the stock could rebound. As one expert noted, the current valuation already “prices in” much of the near-term risk ts2.tech. On the flip side, if macro pressures persist, DECK may stay volatile.

For now, analysts broadly view Deckers with guarded optimism. Ratings skew toward Hold/Buy (none extreme), and the brand story (Hoka and UGG) remains compelling. But short-term sentiment is wary: Deckers’ beaten-down share price reflects the uncertainty in retail right now. Over the coming months, the market will see whether the company’s premium brands can defy the weak backdrop or if cost headwinds continue to bite.

Sources: Cited company filings and press releases Deckers Deckers; financial news reports and analyses ts2.tech ts2.tech Reuters Reuters; market commentary ts2.tech ts2.tech Marketbeat; sector and economic data Reuters Reuters Reuters. These sources provide the latest stock data, earnings figures and expert insights as of Oct. 24, 2025.

Stock Market Today

  • Nanobiotix reports 2025 voting rights and share capital
    January 13, 2026, 5:27 PM EST. Nanobiotix S.A. published its year-end voting rights and share capital data for 2025. As of December 31, 2025, it had 48,410,068 shares outstanding and total voting rights of 50,109,170, with theoretical voting rights at 50,087,052. The disclosure complies with Article L.233-8 II of the French Commercial Code and AMF Regulation, clarifying how voting rights are calculated, including suspended rights. Nanobiotix is listed on Euronext Paris and Nasdaq, underscoring market transparency.
Scienture Holdings (SCNX) Stock Skyrockets on FDA Drug Launch – Will the Rally Last?
Previous Story

Scienture Shares Skyrocket 350% on FDA-Approved Drug Launch – What’s Next?

Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet
Next Story

Qualigen (QLGN) Stock Rockets on Crypto Pivot – But Experts Warn It’s a Risky Bet

Go toTop